Lower middle-market healthcare M&A is gaining momentum thanks to regulatory and tech tailwinds, with standout potential in home-based care, primary care, pharmacy and consumer health. One firm, in particular, is buying, selling at attractive multiples and raising ever bigger funds like it was 2019.
To read the entire story, you must be logged in.
Please log in now or register with us.
